Company newsMRNA
Explain this story: Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.
Explain like I'm 7
Moderna made a cancer vaccine using mRNA, and tests show it works. Now it will show more at a big science meeting.
Other · Cancer vaccine data ahead of oncology meeting presentationBarron'sSector and industry: HealthcareBiotechnologyTell me moreShow less
Explain like I'm 7
Moderna made a cancer vaccine using mRNA, and tests show it works. Now it will show more at a big science meeting.
What happenedFrom the article
- Moderna's surged after proving the efficacy of its personalized cancer vaccine, intismeran autogene.
- The company is preparing to present three abstracts for this mRNA cancer vaccine at the European Society for Medical Oncology's annual meeting.
- Investors are watching for the next developments on the treatment.
Why investors careOur explanation
A cancer vaccine that shows efficacy, meaning it works as intended in testing, could eventually become a source of if it clears further testing and